Search Results 891-900 of 16897 for SARS-CoV-2

  1. A Study to Compare Nasal Swabs to Detect Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

    A Study to Compare Nasal Swabs to Detect Severe Acute Respiratory Syndrome Coronavirus 2 ... Having sign/symptoms of COVID-19 and/or prior diagnosis of COVID-19.

  2. Mayo Clinic Q&A podcast: Long-term care facilities take precautions against COVID-19 (coronavirus)

    Long-term care facilities are taking steps to prepare and respond to the COVID-19 (coronavirus) pandemic. With guidance from the Centers for Disease Control ...

  3. Mayo Clinic Q&A podcast: Building a wall of immunity against COVID-19

    Dr. Berbari also addresses additional COVID-19 vaccine doses for immunocompromised people, the importance of masking, even if vaccinated, and he answers a ...

  4. Mycophenolate (oral route) - Side effects & dosage - Mayo Clinic

    ... virus-associated nephropathy (BKVAN), polyoma virus-associated nephropathy (PVAN), or SARS-CoV-2 (COVID-19) infection. CMV can cause serious tissue and ...

  5. Macroglobulinemia Clinical Trials - Mayo Clinic Research

    Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and ...

  6. HEERF I - CARES Act - COVID-19 Updates - Mayo Clinic College of Medicine & Science

    CARES Act (COVID-19) emergency grant information for students at Mayo Clinic College of Medicine and Science.

  7. Publications - William G. Morice, II, M.D., Ph.D. - Mayo Clinic

    Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology. Popul Health Manag. 2023 Feb; 26 (1):29-36

  8. MCCMS Learner COVID-19 Exposure Guidance

    The information is adapted from the “Supervisor Guidance for Employee Testing and Diagnosis” materials found on the COVID-19 Information Center. Important ...

  9. Rituximab (intravenous route) - Side effects & uses - Mayo Clinic

    SARS-COV-2 (COVID-19) Vaccine, Adenovirus 26 Vector (Janssen); SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna); SARS-COV-2 (COVID-19) Vaccine, mRNA (Pfizer).

  10. Update on Mayo Clinic's COVID-19 vaccination plans

    Note: This information was written by the Mayo Clinic COVID-19 Vaccine Work Group. Mayo Clinic continues to follow federal and state guidelines in ...